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Introduction
Malignant melanoma (MM) is one of the most 
aggressive tumors with high metastatic potential. Also the 
incidence of MM has increased in recent years (Simard et 
al., 2012; Gajda and Kaminska, 2014). According to the 
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Abstract
 Background: We defined melanoma distribution in a large series of Turkish patients and evaluated the 
prognostic parameters of melanomas. Materials and Methods: A total of 1574 patients’ data was retrospectively 
collected at 18 centers in Turkey. Demographic characteristics were questioned and noted. Prognostic parametres 
were evaluated based on sentinel lymph node involvement. Results: Mean age was 56.7 (4-99) years. While 844 
(53.6%) cases were male, 730 (46.4%) cases were female. One thousand four hundred forty-seven (92%) cases 
were invasive melanoma and 127 (8%) cases were in-situ melanoma. The most common histopathological form 
was the superficial spreading melanoma (SSM) which was found in 549 patients (37.9%). It was followed by 
nodular melanoma in 379 (26.2%), acral lentiginous melanoma (ALM) in 191 (13.2%) and lentigo maligna 
melanoma in 132 (9.1%), respectively. On univariate analysis, lymphovascular invasion (p<0.001), tumor 
thickness (p<0.001), histopathological subtype (p<0.001), Clark level (p=0.001), ulceration (p<0.001), ≥6/mm2 
mitosis (p=0.005), satellite formation (p=0.001) and gender (p=0.03) were found to be associated with sentinel 
lymph node positivity. Regression was associated with sentinel lymph node negativity (p=0.017). According to 
multivariate analysis, lymphovascular invasion and tumor thickness were significant independent predictive 
factors of SLN positivity. Patient age, tumor localization, precursor lesions, lymphocytic infiltration and 
neurotropism were not related with sentinel lymph node involvement. Conclusions: In this retrospective analysis, 
it was found that the prevalence of SSM is at a lower rate while the prevalence of ALM is at a higher rate when 
compared to western countries. According to Breslow index; most of the melanoma lesions’ thickness were 
greater than 2 mm, corresponding Clark IV. Vascular invasion and tumor thickness are the most important 
factors for sentinel lymph node involvement.  
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GLOBOCAN-2012, the incidence of melanoma is highest 
in Australia/ New Zealand: 10.5 new cases in men and 
10 in women, annually, per 100,000. The incidence in 
Northern America is 4.7/100,000 for men and 3.6/100,000 
for women, in Euorope it is 2.9/100,000, in Latin America 
and Carribean 1.3/100,000 in Africa 0.8/100,000 and in 
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Asia it is 0.3/100,000 in descending order (Ferlay et al., 
2013). It is estimated that there are 752 new MM cases 
in men and 800 new MM cases in women in Turkey. 630 
cases were died because of MM (Ferlay et al., 2013). Its 
incidence ranges from 0,7 to 2,3 in Turkey, per 100,000 
(Eser et al., 2010; Ferlay et al., 2013).
Growth phase (vertical or radial) that is the first 
important morphological prognostic factor is used to 
distinguish between melanoma in-situ (Mis) and MM. 
Staging system published in 2009 by American Joint 
Committee on Cancer (AJCC) has also been frequently 
used nowadays for MM (Balch et al., 2009). 
Histopathologically, Breslow tumor thickness, mitotic 
rate, and presence or absence of ulceration are the most 
important prognostic and staging factors in MM (Balch et 
al., 2009). In addition these parameters, level of invasion 
(Clark method), lymphovascular invasion, perineural 
infiltration, regression, microsatellitosis and tumor 
infiltrating lymphocytes are generally accepted criteria in 
a routine pathology report (Frishberg et al., 2009).
As Turkish dermatopathology study group, we believe 
that our study is the largest series from Turkey with its 
detailed histopathological results. The main goal of this 
study was to display the descriptive statistics of clinical 
and histopathological profile of primary cutaneous 
melanoma in Turkish patients in a period of five years 
(2008-2012), and to compare them with data of literature. 
In addition, we evaluated the prognostic factors based on 
the SLN involvement.
Materials and Methods
Appropriate permission for the study was obtained 
from Ethic Committee of Hacettepe Medical Faculty 
(approval no: GO 14/03-47). The study was designed as 
a retrospective clinical and histopathological features on 
cutaneous MM patients. Firstly prognostic parameters 
were determined and sent to the participants of Turkish 
dermatopathology study group. Then a common database 
was created by email from participants. One thousand 
five hundred seventy-four patients to whom performed 
excisional biopsy between 2008 and 2012 selected in the 
study. Non-cutaneous MM is excluded from the study. 
Variables consisted of clinical features of the 
patients (age, gender and localization), current published 
prognostic and predictive factors including histological 
subtype, presence or absence of ulceration, Breslow tumor 
thickness, Clark level of invasion, pT, neurotropism, 
satellitosis (absent, microsatellitosis or macrosatellitosis), 
growth phase (radial, vertical or both of them), regression 
(absent, mild: ≤50%, moderate: >50% or complete), 
lymphocytic infiltration (absent, nonbrisk or brisk), 
precursor lesions and treatment (surgical excision, 
presence of sentinel or other lymph node dissection).
The age of patients were classified into three different 
groups: ≤20, 21-40 and ≥41 years old. Primary tumors 
were categorized into seven distinct groups based on 
the anatomical sites: head and neck, front side of the 
trunk, back side of the trunk, upper extremities, lower 
extremities, scalp, axillary-pubic region. According to 
the AJCC staging system, tumor thickness was classified 
into four groups: 0-1mm, >1-2 mm, >2-4 mm and >4mm. 
The level of tumor invasion was also categorized by 
using Clark level system. The histological subtype of 
primary tumor was grouped based on WHO classification: 
superficial spreading melanoma, nodular melanoma, 
lentigo malign melanoma, acral lentiginous melanoma, 
desmoplastic melanoma and neurotropic melanoma, 
melanoma arising from blue nevus, melanoma arising 
in giant congenital nevus, childhood melanoma, nevoid 
melanoma, persistent melanoma and local metastasis of 
melanoma and unclassified type 
Statistical analysis: After the all data were enterred 
into computer, they were assessed by SPSS for Windows 
version 15.0 (SPSS Inc. Chicago, IL, US). Frequency, 
percentage, average and standard deviation were given as 
a descriptive statistical value. Differences between groups 
were tested for significance by chi-square test. Logistic 
regression analysis was also used to investigate the 
multivariate relationship of clinical and pathologic factors 
predicting SLN positivity. Differences were considered as 
significant at P<0.05.
Results 
Between 2008 and 2012, a total of 1574 patients’ data 
was sended from 18 centers in Turkey. Mean age was 56.7 
(4-99) years. Twenty-six cases (1.7%) were 20≤ years old. 
Two hundred and sixty-six cases (17%) were between 
21-40 years old. One thousand two hundred eighty-two 
cases (81.4%) were 41≥ years old. While 844 (53.6%) 
cases were male, 730 (46.4%) cases were female. One 
thousand four hundred forty-seven (92%) of 1574 cases 
were invasive melanoma, 127 (8%) cases were melanoma 
in-situ. The most common Mis form was lentigo maligna 
(70; 55%), followed by superficial spreading type Mis 
(39; 31%), unclassified type Mis (14; 11%) and acral 
lentiginous type Mis (4; 3%). 
 In following years, according to our database there 
were 383 MM cases in 2008, 261 cases in 2009, 308 
cases in 2010, 293 cases in 2011 and 329 cases in 2012, 
respectively. The most common site of MM was lower 
extremity (27.3%), followed by head and neck (25.7%), 
and trunk (23.1%). The lower extremity was the most 
common localization in both sexes (Table 1). The most 
common histopathological form was the superficial 
spreading melanoma (SSM), which was found in 549 
patients (37.9%), followed by nodular melanoma (NM) 
in 379 (26.2%), acral lentiginous melanoma (ALM) 
in 191 (13.2%), lentigo maligna melanoma (LMM) in 
132 (9.1%) , nevoid melanoma in 16 (1.1%), persistent 
melanoma in 14 (1%), desmoplastic melanoma in 10 
(0.7%), melanoma developing from congenital nevus in 
9 (0.6%), melanoma developing from blue nevus in 5 
(0.3%), childhood melanoma in 6 (0.4%) and unclassified 
type in 136 (9.4%) (table 2). 
While the median Breslow thickness was 2,7 
mm, majority of tumors were in Clark level IV (650; 
44.9%). pT4b (363; 25.1%) was the most common 
stage. Ulceration was present in 651 (45%) cases. While 
majority of MMs (51.3 %) showed non-brisk lymphocytic 
infiltration, 31.3% of MMs possessed brisk lymphocytic 
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infiltration. Lymphovascular invasion were seen in 10.6% 
of all cases. Microsatellite formation was observed in 
5.4%, whereas macrosatellit formation was seen in 1.4% 
of cases. Partial, marked and complete regression was 
present in 18.2%, 3.1% and 0.4% of cases, respectively. 
Neurotropism was found in 18.3% of all cases. The most 
common precursor lesion was ordinary nevus (9.1%), 
followed by dysplastic nevus (5.3%), congenital nevus 
(0.6%) and blue nevus (0.3%). 
SLN biopsy was performed in 417 patients. Metastases 
of SLN was noticed in 37.2% (155/417) of these patients. 
Lymphadenectomy was performed in 302 cases. Metastases 
of other lymph nodes were detected in 48.3% (146/302). 
All parameters compared to SLN positive and negative 
patients. On univariate analysis, lymphovascular invasion 
(p<0.001), tumor thickness (p<0.001), histopathological 
subtype (p<0.001), Clark level (p=0.001), ulceration 
(p<0.001), ≥6/mm2 mitosis (p=0,005), satellite formation 
(p=0.001) and gender (p=0.03) were found to be associated 
with SLN involvement. Regression was associated with 
SLN negativity (p=0.017). On multivariate analysis, 
independent characteristics of the melanoma among 
the prognostic variables were lymphovascular invasion 
and tumor thickness (table 3). SLN involvement was 
not statistically significant relation with age, tumor 
localization, lymphocytic infiltration, precursor lesions 
and neurotropism. 
Discussion
Melanoma localization varies according to gender 
in literature. While MM is most often seen on the back 
of the trunk in men, it is predominantly seen on the 
lower extremities in women (Weedon, 2010). However, 
a previous study revealed that the tumors of trunk and 
extremities did not show gender differences (Gyrylova 
et al., 2014). In our study, the most common sites were 
lower extremity followed by the head and neck for both 
sex. MM effects mostly elderly patients, with a peak of 
incidence around the sixth decade of life (LeBoit et al., 
2006). In our study, the mean age found was 56.7 years. 
Acording to a recent study, the lesions of the head and 
neck, older age, and male sex were associated with an 
increased risk of recurrence after a negative SLNB result 
(Jones et al., 2013). In addition, the overall survival (OS) 
of men with melanoma was also worse compared to those 
of women in a study from Turkey (Uysal-Sonmez et al., 
Table 1. Anatomic Distribution of MM by Gender
 Male Female
Head and Neck 175 (12.1%) 197 (13.6%)
Frontal Side of the Trunk 75   (5.2%) 29   (2%)
Back Side of the Trunk 154 (10.6%) 68   (4.7%)
Upper Extremity 105   (7.3%) 113   (7.8%)
Lower Extremity 189 (13.1%) 206 (14.7%)
Scalp 41  (2.8%) 13   (0.9%)
Axillar and Pubic 12  (0.8%) 18   (1.2%)
Trunk 5  (0.3%) 3   (0.2%)
Unknown 23  (1.6%) 21   (1.5%)
Table 2. Histopathological Subtype Distribution of 
Mis and MM
Histopathological subtype n (%)
Melanoma in-situ 
     Lentigo maligna 70   (55)
     Superficial spreading type 39   (31)
     Unclassified type Mis 14   (11)
     Acral lentiginous type 4     (3)
     Total 127 (100)
Malignant Melanoma  
     Superficial spreading melanoma 549   (37.9)
     Nodular melanoma 379   (26.2)
     Acral lentiginous melanoma 191   (13.2)
     Lentigo maligna melanoma  132     (9.1)
     Nevoid melanoma 16     (1.1)
     Persistent melanoma 14     (1)
     Desmoplastic melanoma 10     (0.7)
     Melanoma developing from congenital nevus 9     (0.6)
     Childhood melanoma 6     (0.4)
     Melanoma developing from blue nevus 5     (0.3)
     Unclassified type 136     (9.4)
     Total    1447 (100)
0
25.0
50.0
75.0
100.0
N
ew
ly
 d
ia
gn
os
ed
 w
ith
ou
t 
tr
ea
tm
en
t 
N
ew
ly
 d
ia
gn
os
ed
 w
ith
 t
re
at
m
en
t 
Pe
rs
is
te
nc
e 
or
 r
ec
ur
re
nc
e
Re
m
is
si
on
N
on
e
Ch
em
ot
he
ra
py
Ra
di
ot
he
ra
py
Co
nc
ur
re
nt
 c
he
m
or
ad
ia
tio
n
10.3
0
12.8
30.025.0
20.310.16.3
51.7
75.0
51.1
30.031.3
54.2
46.856.3
27.625.0
33.130.031.3
23.7
38.0
31.3
N
ew
ly
 d
ia
gn
os
ed
 w
ith
ou
t 
tr
ea
tm
en
t 
N
ew
ly
 d
ia
gn
os
ed
 w
ith
 t
re
at
m
en
t 
Pe
rs
is
te
nc
e 
or
 r
ec
ur
re
nc
e
Re
m
is
si
on
N
on
e
Ch
em
ot
he
ra
py
Ra
di
ot
he
ra
py
Co
nc
ur
re
nt
 c
he
m
or
ad
ia
tio
n
Table 3. Statistical Evaluation of Histopathological 
Parameters
  SLN  SLN  P* P** 
  positive negative
Histological subtype
 SSM 49 132 <0.001 
 NM 55 46  
 ALM 31 43  
 LMM 2 17  
 Others 18 24  
Clark level
 II 4 19 0.001 
 III 32 82  
 IV 80 128  
 V 39 33  
Tumor thickness (mm)
 ≤1 6 46 <0.001 0.002
 1.1-2 24 76  
 2.1-4 47 76  
 >4 78 64  
Ulcer
 Present 99 112 <0.001 
 Absent 56 150  
Mitosis (mm2)
 <6 91 200 0.005 
 ≥6 64 62  
Lymphovascular invasion
  Absent 103 251 <0.001 <0.001
 Present 52 11  
Satellite formation
 Absent 143 258 0.001 
 Micro 12 2  
 Macro 0 2  
Regression
 Absent 127 187 0.017 
 <%50 25 64  
 ≥%50 3 11  
*Chi-square test, **Binary logistic regression analysis; SLN: 
Sentinel lymph node, SSM: superficial spreading melanoma, 
NM: nodular malignant melanoma, ALM: acral lentiginous 
melanoma, LMM: lentigo maligna melanoma
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2013). Although being older than 65 years was found 
to be an independent prognostic factor of OS, gender 
and tumor localization were not associated with OS and 
disease-free survival (DFS) (Wu et al., 2013). However, 
another study reported that tumor location, gender and 
age were not correlated with DFS and OS (Namikawa et 
al., 2012). In another study from Japan, age and gender 
were not associated with DFS for patients with thick 
melanoma (Fujisawa et al., 2012). In our study, male 
gender was associated with SLN positivity but it was not 
an independent predictive factor on multivariate analysis. 
In addition, SLN involvement was not statistically 
significant relation with age and tumor localization.
SSM is the most common subtype and accounts for 
60-70% of all MM in Caucasians. NM is the second most 
frequent subtype and constitutes 10-15% of all melanomas 
in light-skinned people (LeBoit et al., 2006). Acral 
melanoma forms 2% and 80% of cutaneous melanomas 
in Caucasian and heavily pigmented people, respectively 
(LeBoit et al., 2006). Some studies from Asia have 
reported that ALM is the most common form in MM and 
its frequency is about 50%. (Chang et al., 2004; Lee et al., 
2012). The most common histopathological form in our 
study was SSM (37.9%), followed by NM (26.2%) and 
ALM (13.2%). Our study revealed that SSM was lower 
and ALM was higher compared to western countries. 
However, our ALM frequency was similar to another 
study from Turkey but it was not as high as in reported 
studies from Asian countries (Chang et al., 2004; Tas 
et al., 2006; Lee et al., 2012). When the histological 
subtypes which were categorized as ALM and nonALM, 
it was not associated with DFS and OS for patients with 
thick melanoma (Fujisawa et al., 2012). In our study, 
histological subtypes were associated with SLN positivity 
but it was not independent predictive factor. 
The role of elective lymph node dissection (ELDN) in 
treatment process and SLN mapping studies to determine 
the lymphatic invasion are among the most prominent 
changes. To reduce morbidity of ELND, intraoperative 
lymphatic mapping and sentinel lymph node biopsy 
(SLNB) are increasingly common used methods (Testori 
et al., 2013). SLNB, when used in appropriate indications 
by ELDN is less time consuming, easy to implement, cost 
advantages, and most importantly for patients comprise 
less morbidity. In our study, SLN data was known in 
417(28.8%) of 1447 patients. 
A previous study revealed that vascular invasion 
was an independent predictive factor of metastasis and 
survival in melanoma (Kashani-Sabet et al., 2001). 
On a multivariate analysis, vascular invasion was the 
second most important factor after the tumor thickness 
(Kashani-Sabet et al., 2001). The prognosis of malignant 
melanoma depends on mostly clinical stage at the time 
of diagnosis. Therefore, Breslow thickness is another 
important predictor of survival (Mervic, 2012). In a 
recent study, it is found to be an independent prognostic 
factor for DFS and OS (Wu et al., 2013). In our study, 
both of them are significant independent predictors on 
multivariate analysis.
Mitotic rate and ulceration are currently the staging 
factors in MM based on AJCC. Another study also reported 
that high mitotic rate (per mm2) was associated with 
poor prognosis and an important independent predictive 
factor of survival (Azzola et al., 2003). However, some 
authors stated that the mitotic rate was not an independent 
prognostic factor because it was significantly associated 
with tumor thickness and ulceration (Weedon, 2010). 
Ulceration is the loss of continuity of the epithelium on 
the surface. The presence of ulceration changes in the 
stage of TNM classification. Ulceration is regarded as 
an independent prognostic factor for melanoma (Ivan 
and Prieto, 2011); yet, some authors have not identified 
ulceration as an independently significant prognostic 
attribute (Azzola et al., 2003, Uysal-Sonmez et al., 
2013, Wu et al., 2013). In addition, another study found 
that ulceration of the primary lesion was significantly 
associated with nodal disease on univariate, but not 
on multivariate analysis (Fontaine et al., 2003). In our 
study, high mitotic rate and presence of ulceration were 
related with SLN involvement on univariate but not on 
multivariate analysis. 
Clarks group classified the lymphocytic infiltrate into 
absent, nonbrisk, and brisk based on distribution and 
intensity (Clark et al., 1989). They also found that tumor-
infiltrating lymphocytes (TIL) were a favorable feature. 
Although some studies have failed to demonstrate such an 
association (Gimotty et al., 2005; Taylor et al., 2007), other 
studies revealed that the presence of TIL in melanoma was 
associated with a favorable prognosis (Bogunovic et al., 
2009; Mandala et al., 2009; Burton et al., 2011). A previous 
study (Taylor et al., 2007) showed that TILs predicted 
SLN positivity but, in contrast to other study (Azimi et 
al., 2012), were not associated with survival. In addition, 
another study revealed no correlation between TILs and 
SLN positivity (Minutilli et al., 2007). Therefore TIL is 
controversial whether their presence is an independent 
prognostic factor. Evaluation of TIL were also subject to 
considerable interobserver variability (Monshizadeh et 
al., 2012). In our study there was no statistical significant 
relation between TIL and SLN positivity. Regression 
can be recognized by the presence of fibrosis, vascular 
proliferation, melanophages and lymphocytic infiltration. 
Partial regression was associated with poorer prognosis 
(Guitart et al., 2002), due to dermal component could have 
metastasized before it regressed. A previous study revealed 
there were no association between partial regression of 
the primary melanoma and SLN involvement by the 
disease (Fontaine et al., 2003). Another study showed 
that regression in primary cutaneous melanoma is not 
predictive for lymph node metastasis (Alquier-Bouffard 
et al., 2007). In our series, most of case showed partial 
regression and in contrast to literature, we found that the 
regression was related with SLN negativity on univariate 
analysis. But, it was not independent predictor on 
multivariate analysis. When we examine the literature, 
we think that regression is a controversial issue like TIL; 
besides, there was a discrepancy between regression and 
the percence of brisk TIL which is as a potentially different 
form of immunological regression is accepted as good 
prognostic indicator. 
Satellites are defined as discontinuous foci of a primary 
melanoma and it is classified as stage IIIB/C disease. Some 
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authors acclaimed that microsatellites predict locoregional 
relapse but not overall survival (Shaikh et al., 2005). 
Acording to a recent study, SLN positivity rate was 43 % in 
microsatellite patients (Bartlett et al., 2014). However, in 
our study, SLN positivity rate was 85,7 % (12/14) in these 
patients. In addition, being of satellites was found to be 
associated with SLN positivity, but it was not independent 
predictor on multivariate analysis.
As a result, vascular invasion and tumor thickness are 
significant independent predictors for SLN involvement. In 
our study, we had a large series of cases that were collected 
for 5 years. Although these study have been performed 
in major consultation centers, further population based 
multicentric studies presented each region of Turkey are 
necessary to determine epidemiologic values in Turkish 
patients.
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